Caren Grossbard Solomon, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Climate Change | 5 | 2022 | 418 | 1.640 |
Why?
|
| Climate | 2 | 2022 | 147 | 1.470 |
Why?
|
| Pre-Eclampsia | 11 | 2017 | 1200 | 1.070 |
Why?
|
| Pregnancy Complications, Cardiovascular | 7 | 2011 | 500 | 1.040 |
Why?
|
| Environmental Pollution | 2 | 2022 | 118 | 0.990 |
Why?
|
| Diabetes, Gestational | 16 | 2015 | 1184 | 0.860 |
Why?
|
| Fossil Fuels | 1 | 2022 | 44 | 0.850 |
Why?
|
| Air Pollution | 4 | 2022 | 2286 | 0.730 |
Why?
|
| Pregnancy Proteins | 2 | 2016 | 229 | 0.720 |
Why?
|
| Global Warming | 1 | 2020 | 64 | 0.710 |
Why?
|
| Hypertension, Pregnancy-Induced | 6 | 2016 | 489 | 0.680 |
Why?
|
| Glucose Intolerance | 7 | 2014 | 577 | 0.660 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 2 | 2016 | 552 | 0.620 |
Why?
|
| Health | 1 | 2019 | 394 | 0.560 |
Why?
|
| Estrogen Replacement Therapy | 3 | 2016 | 1203 | 0.490 |
Why?
|
| Disease | 1 | 2019 | 680 | 0.460 |
Why?
|
| Air Pollutants | 3 | 2022 | 2817 | 0.450 |
Why?
|
| Hypertension | 11 | 2022 | 8480 | 0.450 |
Why?
|
| Pregnancy Outcome | 5 | 2015 | 2795 | 0.440 |
Why?
|
| Pregnancy Complications | 7 | 2015 | 2861 | 0.410 |
Why?
|
| Physician's Role | 1 | 2019 | 943 | 0.400 |
Why?
|
| Antihypertensive Agents | 6 | 2015 | 2046 | 0.370 |
Why?
|
| Pregnancy | 36 | 2017 | 29144 | 0.370 |
Why?
|
| Osteoporosis, Postmenopausal | 3 | 2003 | 386 | 0.360 |
Why?
|
| Estradiol | 1 | 2016 | 2020 | 0.320 |
Why?
|
| Postmenopause | 1 | 2016 | 2461 | 0.290 |
Why?
|
| Ramipril | 1 | 2006 | 95 | 0.280 |
Why?
|
| Public Health | 1 | 2019 | 2603 | 0.270 |
Why?
|
| Aspirin | 1 | 2017 | 3282 | 0.260 |
Why?
|
| Weight Gain | 8 | 2016 | 2292 | 0.260 |
Why?
|
| Diabetes Mellitus, Type 2 | 14 | 2022 | 11725 | 0.250 |
Why?
|
| Menstrual Cycle | 3 | 2022 | 551 | 0.240 |
Why?
|
| Prenatal Care | 5 | 2015 | 1092 | 0.240 |
Why?
|
| Obesity | 11 | 2016 | 12745 | 0.230 |
Why?
|
| Authorship | 1 | 2006 | 271 | 0.230 |
Why?
|
| Gastroplasty | 1 | 2004 | 142 | 0.220 |
Why?
|
| Exercise | 11 | 2015 | 5615 | 0.220 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 3 | 2007 | 1518 | 0.220 |
Why?
|
| Postnatal Care | 2 | 2015 | 236 | 0.220 |
Why?
|
| Bibliometrics | 1 | 2006 | 339 | 0.210 |
Why?
|
| Risk Factors | 39 | 2022 | 72290 | 0.210 |
Why?
|
| Blood Glucose | 7 | 2014 | 6256 | 0.210 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3133 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3240 | 0.210 |
Why?
|
| Oligomenorrhea | 1 | 2001 | 45 | 0.200 |
Why?
|
| Oxygen Inhalation Therapy | 2 | 2015 | 367 | 0.200 |
Why?
|
| Delivery of Health Care | 1 | 2019 | 5319 | 0.190 |
Why?
|
| Periodicity | 1 | 2002 | 363 | 0.190 |
Why?
|
| Cardiovascular Diseases | 9 | 2022 | 15165 | 0.180 |
Why?
|
| Body Mass Index | 15 | 2016 | 12720 | 0.180 |
Why?
|
| Motor Activity | 4 | 2013 | 2714 | 0.180 |
Why?
|
| Fetal Macrosomia | 2 | 2015 | 124 | 0.180 |
Why?
|
| Physicians, Women | 1 | 2006 | 486 | 0.180 |
Why?
|
| Atherosclerosis | 1 | 2016 | 3445 | 0.180 |
Why?
|
| Health Behavior | 5 | 2019 | 2636 | 0.180 |
Why?
|
| Humans | 81 | 2022 | 744343 | 0.180 |
Why?
|
| Coronary Disease | 7 | 2007 | 6077 | 0.170 |
Why?
|
| Diphosphonates | 2 | 2002 | 623 | 0.170 |
Why?
|
| Hypercholesterolemia | 3 | 2022 | 1151 | 0.170 |
Why?
|
| Diabetic Angiopathies | 2 | 2002 | 818 | 0.160 |
Why?
|
| Female | 63 | 2022 | 380194 | 0.160 |
Why?
|
| Faculty, Medical | 1 | 2006 | 1181 | 0.150 |
Why?
|
| Health Maintenance Organizations | 1 | 2000 | 642 | 0.150 |
Why?
|
| Informed Consent | 2 | 2015 | 995 | 0.150 |
Why?
|
| Insulin Resistance | 3 | 2014 | 3864 | 0.150 |
Why?
|
| Cities | 1 | 2019 | 513 | 0.150 |
Why?
|
| Coronary Artery Disease | 1 | 2016 | 6487 | 0.140 |
Why?
|
| Gastric Bypass | 1 | 2004 | 812 | 0.140 |
Why?
|
| Adrenergic Agonists | 1 | 1995 | 58 | 0.130 |
Why?
|
| Kidney Failure, Chronic | 1 | 2008 | 2538 | 0.130 |
Why?
|
| Imidazoles | 1 | 2002 | 1206 | 0.130 |
Why?
|
| Insulin | 6 | 2005 | 6580 | 0.130 |
Why?
|
| Periodicals as Topic | 1 | 2006 | 1432 | 0.130 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 1999 | 370 | 0.130 |
Why?
|
| Taxes | 1 | 2017 | 221 | 0.130 |
Why?
|
| Puerto Rico | 5 | 2016 | 356 | 0.130 |
Why?
|
| Public Opinion | 1 | 2019 | 477 | 0.130 |
Why?
|
| Vulnerable Populations | 1 | 2020 | 687 | 0.120 |
Why?
|
| Absorptiometry, Photon | 1 | 2000 | 1725 | 0.120 |
Why?
|
| Paraneoplastic Endocrine Syndromes | 1 | 1994 | 31 | 0.120 |
Why?
|
| Bicycling | 1 | 1995 | 176 | 0.120 |
Why?
|
| Disasters | 1 | 2020 | 511 | 0.120 |
Why?
|
| Propranolol | 1 | 1995 | 502 | 0.120 |
Why?
|
| Osteomalacia | 1 | 1994 | 53 | 0.120 |
Why?
|
| Norepinephrine | 2 | 1995 | 909 | 0.120 |
Why?
|
| Adrenal Glands | 1 | 1996 | 546 | 0.110 |
Why?
|
| Retinopathy of Prematurity | 2 | 2015 | 421 | 0.110 |
Why?
|
| Nurses | 5 | 2003 | 2461 | 0.110 |
Why?
|
| Prospective Studies | 25 | 2022 | 53288 | 0.110 |
Why?
|
| Postpartum Period | 2 | 2014 | 1086 | 0.110 |
Why?
|
| Epinephrine | 2 | 1995 | 792 | 0.110 |
Why?
|
| Hyperaldosteronism | 1 | 1996 | 240 | 0.110 |
Why?
|
| United States Food and Drug Administration | 1 | 2020 | 1584 | 0.110 |
Why?
|
| Oxygen | 2 | 2015 | 4189 | 0.110 |
Why?
|
| Glucose Tolerance Test | 4 | 2013 | 1150 | 0.110 |
Why?
|
| Human Experimentation | 1 | 2013 | 127 | 0.110 |
Why?
|
| Feeding Behavior | 2 | 2015 | 3188 | 0.100 |
Why?
|
| Cushing Syndrome | 1 | 1994 | 249 | 0.100 |
Why?
|
| United States | 15 | 2020 | 69872 | 0.100 |
Why?
|
| Adult | 44 | 2022 | 214055 | 0.100 |
Why?
|
| Hypercalcemia | 1 | 1994 | 409 | 0.100 |
Why?
|
| Bone Density | 2 | 2002 | 3468 | 0.100 |
Why?
|
| Parity | 3 | 2009 | 929 | 0.100 |
Why?
|
| Acromegaly | 1 | 1994 | 346 | 0.100 |
Why?
|
| Politics | 1 | 2017 | 791 | 0.090 |
Why?
|
| Risk Reduction Behavior | 2 | 2015 | 1125 | 0.090 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1995 | 1240 | 0.090 |
Why?
|
| Cholesterol | 1 | 1999 | 2917 | 0.090 |
Why?
|
| Diabetes Mellitus | 2 | 2006 | 5751 | 0.090 |
Why?
|
| Glycemic Index | 3 | 2006 | 395 | 0.090 |
Why?
|
| Infant, Premature, Diseases | 1 | 2015 | 706 | 0.090 |
Why?
|
| Birth Weight | 2 | 2015 | 2069 | 0.080 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2011 | 440 | 0.080 |
Why?
|
| Respiration | 1 | 1995 | 1653 | 0.080 |
Why?
|
| Multivariate Analysis | 10 | 2014 | 12245 | 0.080 |
Why?
|
| Alcohol Drinking | 2 | 2001 | 3966 | 0.080 |
Why?
|
| Fetal Growth Retardation | 1 | 2011 | 570 | 0.080 |
Why?
|
| Norway | 1 | 2008 | 448 | 0.070 |
Why?
|
| Body Weight | 3 | 2009 | 4669 | 0.070 |
Why?
|
| Hypoglycemia | 1 | 1994 | 861 | 0.070 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2017 | 3068 | 0.070 |
Why?
|
| Luteal Phase | 1 | 2006 | 147 | 0.070 |
Why?
|
| Follicular Phase | 1 | 2006 | 153 | 0.070 |
Why?
|
| Risk | 6 | 2013 | 9687 | 0.070 |
Why?
|
| Gestational Age | 2 | 2011 | 3493 | 0.070 |
Why?
|
| Proinsulin | 1 | 2005 | 133 | 0.070 |
Why?
|
| Incidence | 12 | 2014 | 20947 | 0.060 |
Why?
|
| Insurance, Health | 1 | 2017 | 2494 | 0.060 |
Why?
|
| Cohort Studies | 11 | 2022 | 40561 | 0.060 |
Why?
|
| Thinness | 1 | 2008 | 480 | 0.060 |
Why?
|
| Dominican Republic | 2 | 2014 | 76 | 0.060 |
Why?
|
| Magnesium | 2 | 2006 | 813 | 0.060 |
Why?
|
| Fetus | 1 | 2011 | 1880 | 0.060 |
Why?
|
| Career Mobility | 1 | 2006 | 262 | 0.060 |
Why?
|
| Albuminuria | 1 | 2007 | 682 | 0.060 |
Why?
|
| Pandemics | 2 | 2021 | 8388 | 0.060 |
Why?
|
| Massachusetts | 6 | 2014 | 8663 | 0.060 |
Why?
|
| Meat | 1 | 2006 | 592 | 0.060 |
Why?
|
| Endarterectomy, Carotid | 1 | 2008 | 546 | 0.060 |
Why?
|
| Death | 1 | 2007 | 678 | 0.050 |
Why?
|
| Life Style | 5 | 2014 | 3835 | 0.050 |
Why?
|
| Maternal Age | 2 | 2013 | 802 | 0.050 |
Why?
|
| Dietary Fiber | 1 | 2006 | 760 | 0.050 |
Why?
|
| Health Education | 1 | 2009 | 1056 | 0.050 |
Why?
|
| Blood Pressure | 5 | 2006 | 8554 | 0.050 |
Why?
|
| Stress, Psychological | 2 | 2014 | 4245 | 0.050 |
Why?
|
| Carotid Arteries | 1 | 2006 | 952 | 0.050 |
Why?
|
| Overweight | 2 | 2015 | 2371 | 0.050 |
Why?
|
| Diet | 3 | 2006 | 7939 | 0.050 |
Why?
|
| Sex Distribution | 1 | 2006 | 2297 | 0.050 |
Why?
|
| Regression Analysis | 3 | 2001 | 6459 | 0.050 |
Why?
|
| Middle Aged | 23 | 2022 | 213383 | 0.050 |
Why?
|
| Carotid Stenosis | 1 | 2008 | 854 | 0.050 |
Why?
|
| Hot Flashes | 1 | 2003 | 317 | 0.050 |
Why?
|
| Sunlight | 1 | 2001 | 325 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 7913 | 0.040 |
Why?
|
| Premature Birth | 1 | 2011 | 1721 | 0.040 |
Why?
|
| Eclampsia | 1 | 1999 | 58 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2013 | 9959 | 0.040 |
Why?
|
| Young Adult | 8 | 2022 | 56430 | 0.040 |
Why?
|
| Body Height | 2 | 2002 | 1577 | 0.040 |
Why?
|
| Adolescent | 9 | 2022 | 85781 | 0.040 |
Why?
|
| Immunization, Passive | 1 | 2020 | 623 | 0.040 |
Why?
|
| Child | 3 | 2022 | 77709 | 0.040 |
Why?
|
| Osteoclasts | 1 | 2002 | 729 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2003 | 8642 | 0.040 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 1999 | 183 | 0.040 |
Why?
|
| Walking | 3 | 2001 | 1180 | 0.040 |
Why?
|
| Infant, Newborn | 3 | 2013 | 25625 | 0.040 |
Why?
|
| Women's Health Services | 1 | 2017 | 93 | 0.040 |
Why?
|
| Renin | 2 | 1996 | 642 | 0.040 |
Why?
|
| Nadolol | 1 | 1996 | 30 | 0.040 |
Why?
|
| Smoking | 4 | 2002 | 8987 | 0.040 |
Why?
|
| Cesarean Section | 1 | 2005 | 1365 | 0.040 |
Why?
|
| Kidney Diseases | 1 | 2007 | 2149 | 0.030 |
Why?
|
| Foam Cells | 1 | 1996 | 71 | 0.030 |
Why?
|
| Stents | 1 | 2008 | 3280 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 2 | 2013 | 1677 | 0.030 |
Why?
|
| Trust | 1 | 2020 | 505 | 0.030 |
Why?
|
| Nifedipine | 1 | 1996 | 226 | 0.030 |
Why?
|
| Case-Control Studies | 5 | 2005 | 21746 | 0.030 |
Why?
|
| Myocardial Infarction | 3 | 2002 | 11727 | 0.030 |
Why?
|
| State Health Plans | 1 | 2017 | 216 | 0.030 |
Why?
|
| Saphenous Vein | 2 | 1996 | 532 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 2002 | 1359 | 0.030 |
Why?
|
| Popliteal Vein | 1 | 1994 | 43 | 0.030 |
Why?
|
| Lactates | 1 | 1995 | 432 | 0.030 |
Why?
|
| Longevity | 1 | 2022 | 1070 | 0.030 |
Why?
|
| Endothelin-1 | 1 | 1996 | 314 | 0.030 |
Why?
|
| Chelation Therapy | 1 | 1994 | 67 | 0.030 |
Why?
|
| Aminoglutethimide | 1 | 1994 | 15 | 0.030 |
Why?
|
| Syndrome | 1 | 2001 | 3251 | 0.030 |
Why?
|
| Plicamycin | 1 | 1994 | 13 | 0.030 |
Why?
|
| Potassium | 2 | 1996 | 1336 | 0.030 |
Why?
|
| Edetic Acid | 1 | 1994 | 276 | 0.030 |
Why?
|
| Mitotane | 1 | 1994 | 18 | 0.030 |
Why?
|
| Varicose Ulcer | 1 | 1994 | 52 | 0.030 |
Why?
|
| Propylthiouracil | 1 | 1994 | 69 | 0.030 |
Why?
|
| Diazoxide | 1 | 1994 | 57 | 0.030 |
Why?
|
| Mineralocorticoids | 1 | 1994 | 38 | 0.030 |
Why?
|
| Femoral Vein | 1 | 1994 | 159 | 0.030 |
Why?
|
| Adrenalectomy | 1 | 1996 | 341 | 0.030 |
Why?
|
| Drug Approval | 1 | 2020 | 742 | 0.030 |
Why?
|
| Ketoconazole | 1 | 1994 | 95 | 0.030 |
Why?
|
| Bromocriptine | 1 | 1994 | 111 | 0.030 |
Why?
|
| Depression | 1 | 2013 | 7766 | 0.030 |
Why?
|
| Aldosterone | 2 | 1996 | 877 | 0.030 |
Why?
|
| Inappropriate ADH Syndrome | 1 | 1994 | 61 | 0.030 |
Why?
|
| Hemangiopericytoma | 1 | 1994 | 77 | 0.030 |
Why?
|
| Therapeutic Equipoise | 1 | 2013 | 28 | 0.030 |
Why?
|
| Saline Solution, Hypertonic | 1 | 1994 | 110 | 0.030 |
Why?
|
| Weight Loss | 1 | 2004 | 2622 | 0.030 |
Why?
|
| Octreotide | 1 | 1994 | 145 | 0.030 |
Why?
|
| Logistic Models | 3 | 2013 | 13408 | 0.030 |
Why?
|
| Mifepristone | 1 | 1994 | 150 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2005 | 2872 | 0.030 |
Why?
|
| Registries | 1 | 2008 | 8089 | 0.030 |
Why?
|
| Phosphorus | 1 | 1994 | 338 | 0.030 |
Why?
|
| Calcitonin | 1 | 1994 | 336 | 0.030 |
Why?
|
| Intermittent Claudication | 1 | 1994 | 309 | 0.030 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1994 | 648 | 0.030 |
Why?
|
| Somatostatin | 1 | 1994 | 459 | 0.030 |
Why?
|
| Arteriosclerosis | 1 | 1996 | 1092 | 0.030 |
Why?
|
| Hyperthyroidism | 1 | 1994 | 295 | 0.030 |
Why?
|
| Vasodilator Agents | 1 | 1996 | 977 | 0.020 |
Why?
|
| Myocardial Ischemia | 1 | 2002 | 2148 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 1995 | 1150 | 0.020 |
Why?
|
| Arteries | 1 | 1996 | 1119 | 0.020 |
Why?
|
| Placebos | 1 | 1995 | 1676 | 0.020 |
Why?
|
| Age Factors | 3 | 2008 | 18370 | 0.020 |
Why?
|
| Male | 13 | 2013 | 350118 | 0.020 |
Why?
|
| Follow-Up Studies | 8 | 2007 | 39050 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1995 | 2557 | 0.020 |
Why?
|
| Smoking Cessation | 1 | 2003 | 2071 | 0.020 |
Why?
|
| Exercise Tolerance | 1 | 1995 | 770 | 0.020 |
Why?
|
| Stroke | 3 | 2002 | 9981 | 0.020 |
Why?
|
| Boston | 2 | 2000 | 9313 | 0.020 |
Why?
|
| Socioeconomic Factors | 2 | 2014 | 7785 | 0.020 |
Why?
|
| Fluid Therapy | 1 | 1994 | 593 | 0.020 |
Why?
|
| Sodium, Dietary | 1 | 1993 | 418 | 0.020 |
Why?
|
| Pregnancy Trimester, First | 1 | 2013 | 853 | 0.020 |
Why?
|
| Aged | 10 | 2008 | 163280 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 1995 | 1869 | 0.020 |
Why?
|
| Hormones | 1 | 1993 | 889 | 0.020 |
Why?
|
| Prevalence | 2 | 2014 | 15226 | 0.020 |
Why?
|
| Waist-Hip Ratio | 1 | 2009 | 517 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 1997 | 2585 | 0.020 |
Why?
|
| Menarche | 1 | 2009 | 516 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2013 | 1405 | 0.020 |
Why?
|
| Estrogens | 1 | 1994 | 1566 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2013 | 2539 | 0.020 |
Why?
|
| Odds Ratio | 2 | 2013 | 9849 | 0.020 |
Why?
|
| Medical History Taking | 1 | 2009 | 783 | 0.020 |
Why?
|
| Heart Function Tests | 1 | 2006 | 330 | 0.020 |
Why?
|
| Breast Neoplasms | 2 | 2003 | 20822 | 0.020 |
Why?
|
| Inflammation | 1 | 2005 | 10638 | 0.020 |
Why?
|
| Forecasting | 1 | 1994 | 2951 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2000 | 4558 | 0.010 |
Why?
|
| Cooking | 1 | 2006 | 313 | 0.010 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2005 | 281 | 0.010 |
Why?
|
| C-Peptide | 1 | 2005 | 419 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 1996 | 4456 | 0.010 |
Why?
|
| Age Distribution | 2 | 2002 | 2902 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1996 | 10943 | 0.010 |
Why?
|
| Hypolipidemic Agents | 1 | 2008 | 604 | 0.010 |
Why?
|
| Poverty | 1 | 2015 | 2660 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2013 | 2278 | 0.010 |
Why?
|
| Melanoma | 1 | 2001 | 5510 | 0.010 |
Why?
|
| Blood Pressure Determination | 1 | 2006 | 634 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 2005 | 936 | 0.010 |
Why?
|
| Triage | 1 | 1989 | 976 | 0.010 |
Why?
|
| Creatinine | 1 | 2007 | 1919 | 0.010 |
Why?
|
| Activities of Daily Living | 2 | 2006 | 2418 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 2001 | 5686 | 0.010 |
Why?
|
| Renin-Angiotensin System | 1 | 2006 | 759 | 0.010 |
Why?
|
| Temperance | 1 | 2001 | 89 | 0.010 |
Why?
|
| Macrophages | 1 | 1996 | 5655 | 0.010 |
Why?
|
| Breast Feeding | 1 | 2009 | 1338 | 0.010 |
Why?
|
| Fruit | 1 | 2006 | 1142 | 0.010 |
Why?
|
| Washington | 1 | 2001 | 313 | 0.010 |
Why?
|
| Vegetables | 1 | 2006 | 1182 | 0.010 |
Why?
|
| Survival Rate | 2 | 2007 | 12788 | 0.010 |
Why?
|
| Nutrition Assessment | 1 | 2003 | 723 | 0.010 |
Why?
|
| Thyroid Neoplasms | 1 | 1994 | 2282 | 0.010 |
Why?
|
| Sunburn | 1 | 2001 | 155 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2009 | 2044 | 0.010 |
Why?
|
| Mass Screening | 1 | 1996 | 5255 | 0.010 |
Why?
|
| Glomerular Filtration Rate | 1 | 2007 | 2170 | 0.010 |
Why?
|
| Neoplasms | 2 | 1999 | 21683 | 0.010 |
Why?
|
| Hospitals, Maternity | 1 | 1999 | 42 | 0.010 |
Why?
|
| Indoles | 1 | 2007 | 1839 | 0.010 |
Why?
|
| Magnesium Sulfate | 1 | 1999 | 68 | 0.010 |
Why?
|
| Adiponectin | 1 | 2005 | 1100 | 0.010 |
Why?
|
| Infusions, Intravenous | 2 | 1994 | 2274 | 0.010 |
Why?
|
| Phenytoin | 1 | 1999 | 197 | 0.010 |
Why?
|
| Energy Intake | 1 | 2006 | 2148 | 0.010 |
Why?
|
| Residence Characteristics | 1 | 2008 | 2050 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 1676 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1996 | 19905 | 0.010 |
Why?
|
| Fasting | 1 | 2003 | 1593 | 0.010 |
Why?
|
| Time Factors | 3 | 2008 | 40075 | 0.010 |
Why?
|
| Body Constitution | 1 | 1997 | 278 | 0.010 |
Why?
|
| Reference Values | 1 | 2003 | 4982 | 0.010 |
Why?
|
| Probability | 1 | 2002 | 2505 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2002 | 2971 | 0.010 |
Why?
|
| Giant Cells | 1 | 1996 | 187 | 0.010 |
Why?
|
| Age of Onset | 1 | 2002 | 3271 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2005 | 3200 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2003 | 2187 | 0.010 |
Why?
|
| Plethysmography | 1 | 1994 | 180 | 0.010 |
Why?
|
| Folic Acid | 1 | 2001 | 1300 | 0.010 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 1994 | 205 | 0.010 |
Why?
|
| Pain | 1 | 1989 | 4986 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2005 | 25043 | 0.010 |
Why?
|
| Linear Models | 1 | 2003 | 5952 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2005 | 3778 | 0.010 |
Why?
|
| Blood Volume | 1 | 1994 | 565 | 0.010 |
Why?
|
| Varicose Veins | 1 | 1994 | 154 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1996 | 20129 | 0.010 |
Why?
|
| Glucose Clamp Technique | 1 | 1993 | 266 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2007 | 9146 | 0.010 |
Why?
|
| Cell Count | 1 | 1996 | 1856 | 0.010 |
Why?
|
| Vascular Patency | 1 | 1994 | 886 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 15076 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1993 | 402 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1994 | 1525 | 0.010 |
Why?
|
| Cause of Death | 1 | 2001 | 3584 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2002 | 23338 | 0.010 |
Why?
|
| Growth Hormone | 1 | 1993 | 705 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 1999 | 77449 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1996 | 1504 | 0.010 |
Why?
|
| Leg | 1 | 1994 | 1116 | 0.010 |
Why?
|
| Anticonvulsants | 1 | 1999 | 1916 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 1999 | 2899 | 0.000 |
Why?
|
| Dietary Supplements | 1 | 2001 | 3297 | 0.000 |
Why?
|
| Sodium | 1 | 1993 | 1623 | 0.000 |
Why?
|
| Comorbidity | 1 | 2002 | 10388 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2009 | 41006 | 0.000 |
Why?
|
| Environmental Exposure | 1 | 2001 | 4234 | 0.000 |
Why?
|
| Affect | 1 | 1994 | 1476 | 0.000 |
Why?
|
| Longitudinal Studies | 1 | 2002 | 13989 | 0.000 |
Why?
|
| Dopamine | 1 | 1993 | 1591 | 0.000 |
Why?
|
| Hydrocortisone | 1 | 1993 | 1826 | 0.000 |
Why?
|
| Gene Expression | 1 | 1996 | 7799 | 0.000 |
Why?
|
| Homeostasis | 1 | 1993 | 3340 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1994 | 12026 | 0.000 |
Why?
|